Orchid Pharma updates efforts to maintain minimum public shareholding at 25%; includes past offer for sale and current initiative to raise capital by qualified institutional placement, as well as an application to Securities Exchange Board of India seeking relaxation for one year to meet minimum public shareholding requirement.